Shareholders might have noticed that Shoulder Innovations, Inc. (NYSE:SI) filed its second-quarter result this time last week. The early response was not positive, with shares down 8.0% to US$20.59 in the past week. Revenues were a bright spot, with US$17m in revenue arriving 3.6% ahead of expectations, although statutory earnings didn't fare nearly so well, recording a loss of US$0.49, some 6.7% below consensus predictions. The analysts typically update their forecasts at each earnings report, and we can judge from their estimates whether their view of the company has changed or if there are any new concerns to be aware of. So we gathered the latest post-earnings forecasts to see what estimates suggest is in store for next year.

Taking into account the latest results, the consensus forecast from Shoulder Innovations' four analysts is for revenues of US$68.4m in 2026. This reflects a notable 14% improvement in revenue compared to the last 12 months. Per-share losses are supposed to see a sharp uptick, reaching US$1.89. Before this latest report, the consensus had been expecting revenues of US$67.3m and US$1.71 per share in losses. So it's pretty clear the analysts have mixed opinions on Shoulder Innovations even after this update; although they reconfirmed their revenue numbers, it came at the cost of a considerable increase in per-share losses.

Despite expectations of heavier losses next year,the analysts have lifted their price target 13% to US$26.00, perhaps implying these losses are not expected to be recurring over the long term. There's another way to think about price targets though, and that's to look at the range of price targets put forward by analysts, because a wide range of estimates could suggest a diverse view on possible outcomes for the business. Currently, the most bullish analyst values Shoulder Innovations at US$27.00 per share, while the most bearish prices it at US$25.00. Still, with such a tight range of estimates, it suggeststhe analysts have a pretty good idea of what they think the company is worth.

Taking a look at the bigger picture now, one of the ways we can understand these forecasts is to see how they compare to both past performance and industry growth estimates. It's pretty clear that there is an expectation that Shoulder Innovations' revenue growth will slow down substantially, with revenues to the end of 2026 expected to display 30% growth on an annualised basis. This is compared to a historical growth rate of 61% over the past year. Juxtapose this against the other companies in the industry with analyst coverage, which are forecast to grow their revenues (in aggregate) 7.6% per year. Even after the forecast slowdown in growth, it seems obvious that Shoulder Innovations is also expected to grow faster than the wider industry.

The Bottom Line

The most important thing to take away is that the analysts increased their loss per share estimates for next year. Happily, there were no major changes to revenue forecasts, with the business still expected to grow faster than the wider industry. There was also a nice increase in the price target, with the analysts clearly feeling that the intrinsic value of the business is improving.

Following on from that line of thought, we think that the long-term prospects of the business are much more relevant than next year's earnings. At Simply Wall St, we have a full range of analyst estimates for Shoulder Innovations going out to 2028, and you can see them free on our platform here..

This article by Simply Wall St is general in nature. We provide commentary based on historical data and analyst forecasts only using an unbiased methodology and our articles are not intended to be financial advice. It does not constitute a recommendation to buy or sell any stock, and does not take account of your objectives, or your financial situation. We aim to bring you long-term focused analysis driven by fundamental data. Note that our analysis may not factor in the latest price-sensitive company announcements or qualitative material. Simply Wall St has no position in any stocks mentioned.